AcquisitionAug 6, 2026Completed
🇺🇸 United States
VCVital Connect, Inc. (VitalConnect)IiRhythm Holdings, Inc.
Healthcare › Medical Devices
Enterprise value$288MEnterprise value
AnnouncedAug 6, 2026
ConsiderationCash and stock
StructureNot stated
RegionNorth America
Cross-borderNo
Contingent paymentNo
Overview
iRhythm Holdings and its subsidiary iRhythm Technologies entered into a definitive agreement to acquire privately held Vital Connect, Inc., a wearable biosensor and ambulatory cardiac monitoring company, for total consideration of approximately $287.5 million, consisting of about $237.5 million in cash and about $50 million in iRhythm common stock.
Deal rationale
The acquisition broadens iRhythm's cardiac monitoring portfolio into mobile cardiac telemetry and multi-vitals monitoring, and lets it use its commercial scale to accelerate VitalConnect's growth.
AI-generated from the SEC filingCompletedHealthcare › Medical DevicesUnited StatesNorth America
Timeline
Valuation and terms
| Equity value | Undisclosed | |
|---|---|---|
| Enterprise value | $288M | Headline figure |
| Consideration | Cash and stock |
Advisors
Buy-side
GSGoldman Sachs
Sell-side
None listed
Parties
Target
VCVital Connect, Inc. (VitalConnect)
- Headquarters
- United States
- Ticker
- —